Back to Champlain Investment Partners, LLC

RGEN
Showing 8 of 15 quarters

Position history for Champlain Investment Partners, LLC's holdings in REPLIGEN CORP

Champlain Investment Partners, LLC holds 693,855 shares of RGEN (REPLIGEN CORP), worth $81.7M as of 2026-Q1. The position was decreased (-30.9% shares). RGEN represents 1.0% of Champlain Investment Partners, LLC's portfolio.

Current Value

$81.7M

Current Shares

693,855

Total Value Change

+$9.8M

Total Shares Change

+123,265

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Decreased
693,855
-30.9%
$81.7M1.0%$123.06
0
2025-Q4
Decreased
1M
-25.0%
$164.5M1.7%$166.59
0
2025-Q3
Decreased
1.3M
-4.4%
$179M1.3%$124.09
0
2025-Q2
Decreased
1.4M
-4.3%
$174.3M1.2%$123.56
0
2025-Q1
Decreased
1.5M
-5.2%
$186.3M1.3%$133.41
0
2024-Q4
Increased
1.5M
+8.6%
$222.2M1.4%$143.81
53
2024-Q3
Increased
1.4M
+149.0%
$211.5M1.3%$145.93
78
2024-Q2
Decreased
570,590
-0.8%
$71.9M0.4%$126.06
0

Other major holders of RGEN: BlackRock Finance, Inc., BlackRock, Inc., PRICE T ROWE ASSOCIATES INC /MD/

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used